| Literature DB >> 27880897 |
Colin Havenar-Daughton1, Diane G Carnathan2, Alba Torrents de la Peña3, Matthias Pauthner4, Bryan Briney4, Samantha M Reiss1, Jennifer S Wood5, Kirti Kaushik1, Marit J van Gils3, Sandy L Rosales6, Patricia van der Woude3, Michela Locci1, Khoa M Le4, Steven W de Taeye3, Devin Sok4, Ata Ur Rasheed Mohammed7, Jessica Huang7, Sanjeev Gumber5, AnaPatricia Garcia5, Sudhir P Kasturi8, Bali Pulendran9, John P Moore10, Rafi Ahmed11, Grégory Seumois6, Dennis R Burton12, Rogier W Sanders13, Guido Silvestri9, Shane Crotty14.
Abstract
Generating tier 2 HIV-neutralizing antibody (nAb) responses by immunization remains a challenging problem, and the immunological barriers to induction of such responses with Env immunogens remain unclear. Here, some rhesus monkeys developed autologous tier 2 nAbs upon HIV Env trimer immunization (SOSIP.v5.2) whereas others did not. This was not because HIV Env trimers were immunologically silent because all monkeys made similar ELISA-binding antibody responses; the key difference was nAb versus non-nAb responses. We explored the immunological barriers to HIV nAb responses by combining a suite of techniques, including longitudinal lymph node fine needle aspirates. Unexpectedly, nAb development best correlated with booster immunization GC B cell magnitude and Tfh characteristics of the Env-specific CD4 T cells. Notably, these factors distinguished between successful and unsuccessful antibody responses because GC B cell frequencies and stoichiometry to GC Tfh cells correlated with nAb development, but did not correlate with total Env Ab binding titers. Copyright ÂEntities:
Keywords: vaccines
Mesh:
Substances:
Year: 2016 PMID: 27880897 PMCID: PMC5142765 DOI: 10.1016/j.celrep.2016.10.085
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423